Filters close
11-Jun-2024 3:05 PM EDT
Climate Change-related Disturbances Linked to Worse Cardiovascular Health, Researchers Show
Beth Israel Deaconess Medical Center

Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for approximately one in every three deaths, with more than 20 million deaths reported in 2021 according to a 2024 World Heart Federation report.

   
10-Jun-2024 5:05 PM EDT
In Brief: Multi-omics Analysis Identifies molecularly defined Alzheimer’s disease subtypes
Beth Israel Lahey Health

Investigators used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles to provide novel critical molecular insights into Alzheimer’s Disease (AD) that single-omic analyses cannot offer.

13-May-2024 9:30 AM EDT
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy
Lahey Hospital & Medical Center

One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.

1-Apr-2024 11:00 AM EDT
Chatbot outperformed physicians in clinical reasoning in head-to-head study
Beth Israel Deaconess Medical Center

ChatGPT-4, an artificial intelligence program designed to understand and generate human-like text, outperformed internal medicine residents and attending physicians at two academic medical centers at processing medical data and demonstrating clinical reasoning. In a research letter published in JAMA Internal Medicine, physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) compared a large language model’s (LLM) reasoning abilities directly against human performance using standards developed to assess physicians.

19-Mar-2024 4:05 PM EDT
Researchers Report on the Effectiveness of Skin Biopsy to Detect Parkinson’s and Related Neurodegenerative Diseases
Beth Israel Deaconess Medical Center

In a paper published in the Journal of the American Medical Association (JAMA), neurologists at Beth Israel Deaconess Medical Center (BIDMC) showed that a simple skin biopsy test detects an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson’s disease and the subgroup of neurodegenerative disorders known as synucleinopathies, at high positivity rates.

9-Mar-2024 9:05 AM EST
BIDMC-led trial leads to FDA approval of coronary drug-coated balloons
Beth Israel Deaconess Medical Center

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Released: 5-Mar-2024 3:05 PM EST
Weight-loss surgery provides superior long-term benefits for patients with Type 2 diabetes, study finds
Joslin Diabetes Center

A landmark study conducted at four sites, including Joslin Diabetes Center, reports that people with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to people who received medical management plus lifestyle interventions. Participants who underwent bariatric surgery, also called metabolic or weight-loss surgery, were also more likely to stop needing diabetes medications and had higher rates of diabetes remission up to 12 years post-surgery. The findings, published in JAMA, suggest that weight loss surgery may carry benefits for people with diabetes, even those who are below the traditional BMI threshold of 35 for bariatric surgery.

23-Feb-2024 3:05 PM EST
Shifting focus: Investigators describe changes to pancreatic β cell at onset of Type 1 Diabetes
Joslin Diabetes Center

About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta”) in the pancreas, leading to a lack of insulin and inability to regulate blood sugar. It’s not known why the body suddenly perceives its own β-cells as the enemy; some lines of evidence suggest environmental factors such as viral infections may trigger the onset of T1D, others suggest genetics may also play some role. Groundbreaking research by investigators at Joslin Diabetes Center sheds new light on the specific changes β-cells go through at the onset of T1D. Their findings—published in Nature Cell Biology—offer new avenues for targeted interventions for the chronic autoimmune condition.

Released: 14-Dec-2023 11:05 AM EST
Researchers Pave the Way for Next Generation COVID-19 Immunization Strategies
Beth Israel Deaconess Medical Center

Findings published in the journal Nature by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.

   
8-Dec-2023 11:05 AM EST
AI Chatbot Shows Potential as Diagnostic Partner, Researchers Find
Beth Israel Deaconess Medical Center

Physician-investigators compared a chatbot’s probabilistic reasoning to that of human clinicians. The findings, published in JAMA Network Open, suggest that artificial intelligence could serve as useful clinical decision support tools for physicians.

   
Released: 27-Nov-2023 9:05 AM EST
Alarming Trends in Cardiovascular Health Among Middle-Aged Adults
Beth Israel Deaconess Medical Center

New research helps explain the recent reversal in cardiovascular mortality among this population and underscores the need to address the social determinants of health that contribute to it.

Released: 15-Nov-2023 11:05 AM EST
Researchers Halt Progression in Parkinson's Disease Mouse Model
Beth Israel Deaconess Medical Center

Researchers performed complementary experiments showing that inhibiting a specific enzyme in a mouse model protects the dopamine-producing neurons that are normally lost as Parkinson's disease progresses, effectively halting the progression of the disease. The findings open the door to the development of novel therapeutics targeting the enzyme that may slow or prevent the progression of Parkinson's disease in people—a major unmet need.

Released: 15-Nov-2023 11:05 AM EST
Study Reveals Link Between Neighborhood Environmental Burden and Risk of Cardiovascular Disease
Beth Israel Deaconess Medical Center

A national study demonstrates that neighborhood exposure to environmental hazards is significantly associated with poor cardiovascular health across the United States.

3-Nov-2023 10:05 AM EDT
Abortion Bans Linked to Increase in Children Entering Foster System, Researchers Find
Beth Israel Deaconess Medical Center

With more than 4 million children placed into foster care during the study period, researchers used state-level data to evaluate the link between restricted abortion access and subsequent entries into the foster care system.

Newswise: Beth Israel Lahey Health Launches Heart Transplant Program
Released: 5-Oct-2023 9:05 AM EDT
Beth Israel Lahey Health Launches Heart Transplant Program
Beth Israel Lahey Health

Beth Israel Lahey Health has expanded its cardiovascular services to include heart transplantation based at Beth Israel Deaconess Medical Center.

Newswise: Agents of Change: A BIDMC OBGYN Advocates for Reproductive Justice for All
Released: 2-Oct-2023 3:05 PM EDT
Agents of Change: A BIDMC OBGYN Advocates for Reproductive Justice for All
Beth Israel Deaconess Medical Center

In a commentary published in a special Obstetrics & Gynecology issue on racism and reproductive health, corresponding author Rose L. Molina, MD, MPH, a BIDMC obstetrician-gynecologist, researcher, and activist advancing health equity in pregnancy care, discusses a long-standing pattern of reproductive control within the U.S. immigration enforcement system.

Released: 10-Aug-2023 1:25 PM EDT
Study Reveals Patients Hospitalized with COVID-19 Faced Nearly Twice the Rates of Death After Discharge As Patients with Flu
Beth Israel Deaconess Medical Center

Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.

Released: 9-Aug-2023 1:15 PM EDT
A gutsy move – new study challenges conventional wisdom about nerve cell origins of “the second brain”
Beth Israel Deaconess Medical Center

Researchers present a completely new paradigm describing a developmental pathway by which the enteric nervous system development continues after birth.

Released: 25-Jul-2023 11:35 AM EDT
Older adults who identify as sexual and gender minorities experience disproportionate age-related decline
Beth Israel Deaconess Medical Center

Using an index to describe and compare frailty between older sexual and gender minority (OSGM) adults and non-OSGM participants, researchers showed that OSGM had higher rates of frailty, starting at younger ages and continuing into older age, compared to non-OSGM.

15-Jun-2023 10:15 AM EDT
Researchers test AI-powered chatbot's medical diagnostic ability
Beth Israel Deaconess Medical Center

Researchers tested one well-known publicly available chatbot’s ability to make accurate diagnoses in challenging medical cases. The team found that the generative AI, Chat-GPT 4, selected the correct diagnosis as its top diagnosis nearly 40 percent of the time and provided the correct diagnosis in its list of potential diagnoses in two-thirds of challenging cases.



close
0.14249